Paul S. Tully is a partner with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Tully's practice includes all aspects of patent litigation, due diligence, patent licensing and negotiations, IPO and venture capital due diligence related to intellectual property, patent preparation and prosecution, opinion preparation, preparation and evaluation of secrecy agreements, freedom-to-operate studies, and client counseling. His technology experience includes pharmaceuticals, organic/organometallic chemistry, process chemistry, medicinal chemistry, biotechnology, medical devices, diagnostics, catalysts, and polymer technology. Dr. Tully has extensive litigation experience, including first and second chair representations, across a wide range of technology areas, from discovery through trial/settlement and appeal.
Prior to joining MBHB, Dr. Tully was an organic research chemist, a patent agent, and corporate intellectual property counsel for a medium-sized chemical company.